Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Have you been tested for HLA-A*02:01 and do you have this genetic marker?

This is a genetic test that determines if your immune system can respond to tebentafusp. Without this marker, the drug cannot be effective for you. This test is usually done with a simple blood test.

Show original medical criteria

HLA-A*02:01 positive status is required for tebentafusp to work, as this immunotherapy is designed specifically for patients with this genetic marker.

This is informational only — not medical advice. Always discuss eligibility with your oncologist.

Eligibility Check — Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma — FindMyCure.ai